Harry Al-Wassiti

Experts / Harry Al-Wassiti

Bioengineer and Research Fellow, Monash University

More from this expert

Infectious diseases

Clinical Articles

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Infectious diseases

Clinical Articles

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

By Harry Al-Wassiti

Clinical Articles

Infectious diseases

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

By Harry Al-Wassiti

Clinical Articles

Infectious diseases

Harry Al-Wassiti

Bioengineer and Research Fellow, Monash University

More from this expert

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Premature Ovarian Insufficiency – The New Guidelines

Tuesday 3rd March, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, University of Sydney

Join Prof Rodney Baber AM for this presentation where he will discuss the new guidelines related to POI and the most relevant recommendations that will affect clinical practice and assist in better recognition, understanding, diagnosis and management.

Harry Al-Wassiti

Bioengineer and Research Fellow, Monash University

More from this expert

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Premature Ovarian Insufficiency – The New Guidelines

Tuesday 3rd March, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, University of Sydney

Join Prof Rodney Baber AM for this presentation where he will discuss the new guidelines related to POI and the most relevant recommendations that will affect clinical practice and assist in better recognition, understanding, diagnosis and management.